Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma

Fig. 3

The expression difference of several immune cells markers including (A) MS4A1 (encoding CD20, marker of B cells), (B) IGHG1 (marker of plasma cells), (C) CD19 (encoding CD19, marker of B cells), (D) CD8A (encoding CD8, marker of CD8+ T cells), (E) CD4 (encoding CD4, marker of CD4+ T cells), (F) CD3D (encoding CD3, marker of T cells) and (G-K) expression of several immune checkpoints

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us